Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | FibroBiologics, Inc. Common Stock FBLG | BlackRock Inc. BLK | 750,898 2.000% | -1,035,297 (-57.96%) | Filing History |
| 2025-06-06 3:13 pm Purchase | 2024-08-09 | 13G | FibroBiologics, Inc. Common Stock FBLG | Mike Newlin | 2,134,853 5.579% | 2,134,853 (New Position) | Filing History |
| 2025-02-12 4:01 pm Purchase | 2024-01-31 | 13G | FibroBiologics, Inc. Common Stock FBLG | Peter O'Heeron | 6,951,459 18.200% | 6,951,459 (New Position) | Filing History |
| 2025-01-30 12:43 pm Unchanged | 2024-12-31 | 13G | FibroBiologics, Inc. Common Stock FBLG | BlackRock Inc. BLK | 1,786,195 5.100% | 0 (Unchanged) | Filing History |
| 2025-01-29 4:43 pm Purchase | 2024-12-31 | 13G | FibroBiologics, Inc. Common Stock FBLG | BlackRock Inc. BLK | 1,786,195 5.100% | 1,786,195 (New Position) | Filing History |